Utkars Jain, WG’27, didn’t plan to become an entrepreneur. He planned to go into healthcare to help prevent medical tragedies.
That goal took shape during his teenage years, when his father suffered a cerebral aneurysm and stroke. In the intensive care unit, his father shared a painful memory: As a teenager, he had lost his own father after doctors misdiagnosed chest pain as a heart attack when it was actually a bleeding ulcer. The story stayed with Jain, not just because of the loss, but because it was preventable.
“My father was worried history was repeating itself,” he recalls. “Thankfully, my dad made a full recovery. But that experience prompted my interest in healthcare, and my grandfather’s story inspired me to focus on preventing tragedies that might otherwise be avoidable.”
From Scientist to Founder
Jain pursued that goal at the University of Pittsburgh, earning dual undergraduate degrees in applied mathematics and neuroscience before starting a Ph.D. in bioengineering. Midway through his doctoral program, he began researching technology that could detect cardiac risk earlier — work that would eventually become HEARTio.
“Cardiovascular disease is one of the leading causes of death and disability worldwide, but it’s also one of the most preventable if caught early,” he says. “I started the company with a small group of colleagues (Adam Butchy and Michael Leasure) in 2018 as a passion project. We didn’t think it would go anywhere, and we didn’t have funding.”
But promising results began attracting attention. By 2021, the company had gained enough funding for Jain to step away from his Ph.D. and lead HEARTio full time. Since then, its technology has earned a Breakthrough Device designation from the U.S. Food and Drug Administration, signaling strong potential to address an unmet medical need as it advances through clinical studies toward commercialization. Jain and his co-founders were also recognized in Forbes 30 Under 30 in 2024.
As the company grew, Jain recognized a turning point: Scientific expertise alone wouldn’t be enough to guide it through scaling, fundraising, and strategy. “I know I’m the right person to lead this mission,” he says. “But I didn’t want to be the reason it falls short because I lacked business knowledge.”
Choosing Wharton to Grow as a Leader
That realization led him to Wharton’s MBA Program for Executives (EMBA). For Jain, the decision wasn’t about adding a credential. It was about becoming the kind of CEO his company needs for its next stage.
The impact was immediate. During Orientation Week, Jain practiced his investor pitch with classmates across cohorts. Their feedback, encouragement, and connections helped generate early momentum for his fundraising efforts, opening doors to advisors, investors, and industry leaders.
He credits courses like Economics and Finance with giving him a framework for understanding markets, pricing, and strategy. And through discussions with classmates — many of whom have built, scaled, or exited companies — he’s gaining new perspectives.
“I’m also learning how leaders simplify complex ideas, an essential skill when explaining advanced medical technology to investors, regulators, and partners,” Jain notes, adding that — in his second year — he plans to take courses with the San Francisco and Global cohorts to learn from even more classmates.
Wharton’s network has become a strategic advantage. Through classmates and alumni, Jain has connected with physicians and medical device executives who now advise, invest in, or collaborate with HEARTio. Those relationships, he says, are helping him think more strategically about growth and decision making.
A Different Kind of ROI
For entrepreneurs, Jain believes the return on an MBA is tenfold. It improves judgment, strengthens leadership, and enhances strategic decisions that increase the company’s chances of success.
“Learning from world-renowned professors and classmates who’ve actually built companies is incredible,” he says. “I’m learning from people who’ve done what I aspire to do.”
For those wondering if an MBA is worthwhile, he advises: “If you want to grow a company or yourself as a leader, investing in your own development is one of the most powerful decisions you can make. Since the program began, I’ve seen measurable growth not only in the company, but also my confidence as a CEO. Wharton isn’t just a credential. It’s helping me turn a personal mission into a global health solution.”
By Meghan Laska
Read more about Utkars Jain in Think MBA.
Posted: June 1, 2026
